Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Solu-Medrone (methylprednisolone sodium succinate) 40mg powder and solvent for solution for injection - Important Safety Information from Pfizer Limited as approved by the HPRA
Notice type:
3rd Party Publications
Date:
12/02/2021
Problem Or Issue:
Important Safety Information from Pfizer Limited on the potential risk of medication errors following reformulation from a lactose-containing to a lactose-free formulation of Solu-Medrone (methylprednisolone sodium succinate) 40mg powder and solvent for solution for injection
Important Safety Information - Solu-Medrone (methylprednisolone sodium succinate) 40mg powder and solvent for solution for injection
« Back
Date Printed: 20/05/2024